Louis C. Bock is Director at Orexigen Therapeutics, Inc. (OREX). They have made 15 open-market trades across 4 companies since 2006, most recently 2018-03-12.
CIK 0001279735
6 open-market purchases totalling $18.1M since 2006, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZGNX | SELL | 2018-03-12 | 2018-03-14 | $44.83 | $1.1M | -9.1% | -9.6% | +0.7% |
| ZGNX | SELL | 2018-03-12 | 2018-03-14 | $44.83 | $2.2M | -9.1% | -9.6% | +0.7% |
| OREX | BUY | 2014-11-18 | 2014-11-20 | $5.58 | $7K | N/A | N/A | N/A |
| OREX | BUY | 2014-11-12 | 2014-11-13 | $5.57 | $151K | N/A | N/A | N/A |
| ZGNX | BUY | 2011-09-21 | 2011-09-22 | $2.00 | $2.5M | -27.8% | -4.8% | -4.8% |
| HZNP | BUY | 2011-08-02 | 2011-08-04 | $9.00 | $2.8M | -16.8% | +0.4% | +0.4% |
| ZGNX | BUY | 2010-11-29 | 2010-11-29 | $4.00 | $7.4M | -27.8% | -4.8% | -4.8% |
| OREX | BUY | 2009-07-27 | 2009-07-28 | $7.50 | $2.3M | N/A | N/A | N/A |
| OREX | SELL | 2007-11-21 | 2007-11-21 | $15.00 | $2K | N/A | N/A | N/A |
| OREX | SELL | 2007-11-19 | 2007-11-20 | $15.02 | $42K | N/A | N/A | N/A |
| OREX | SELL | 2007-11-16 | 2007-11-19 | $15.66 | $476K | N/A | N/A | N/A |
| OREX | SELL | 2007-11-16 | 2007-11-19 | $15.53 | $251K | N/A | N/A | N/A |
| OREX | SELL | 2007-11-15 | 2007-11-16 | $15.58 | $23K | N/A | N/A | N/A |
| OREX | SELL | 2007-11-15 | 2007-11-16 | $15.59 | $221K | N/A | N/A | N/A |
| OREX | SELL | 2007-11-14 | 2007-11-16 | $15.54 | $230K | N/A | N/A | N/A |
| SGXP | BUY | 2006-02-06 | 2006-03-28 | $6.00 | $3.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.